January 10, 2023 – Lyon, France
Mablink is the winner of the 9th wave of the i-Nov innovation competition organized by Bpifrance and receives a grant of 1.8 million euros. This is a new proof of the quality of Mablink’s project!
This program, financed by the French government as part of the France 2030 plan and by the European Union as part of the France Recovery Plan, will help to carry out the experiments required to obtain approval for clinical trials of the drug candidate MBK-103, designed for patients suffering from cancers expressing the Folate Receptor alpha, including ovarian cancer.
See the winners of the i-Nov innovation competition – wave 9
…